Pushing the Limits with Nanoknife®: A Promising New Technology in Localised Prostate Cancer Management

Authors:

Caroline Charles,^{1 *}Jean de la Rosette,^{2 *}Mark Emberton3³

1. Scilink Medical Writing, Saint-Pierre-d’Irube, France
2. Department of Urology, AMC University Hospital, Amsterdam, the Netherlands
3. Interventional Oncology, Division of Surgery and Interventional Science,
University College Hospital, London, UK
*Correspondence to [email protected] and [email protected]

Disclosure:

M. Emberton has provided consultancy services to and received research funding from
AngioDynamics Inc., SonaCare Inc., Sophiris Inc., Trod Medical, GSK, and Sanofi; and provided training for AngioDynamics Inc., and SonaCare Inc. J. de la Rosette is a consultant for AngioDynamics Inc.

Support:

Funding for this article was provided by AngioDynamics.

Citation:

EMJ Urol. 2015;3[2]:90-102. DOI/10.33590/emjurol/10311671. https://doi.org/10.33590/emjurol/10311671.

Keywords:

Urology, EAU17.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.